Market Cap ₹257 Cr.
Stock P/E 24.5
P/B 0.6
Current Price ₹64.9
Book Value ₹ 116.2
Face Value 10
52W High ₹79.5
Dividend Yield 0.92%
52W Low ₹ 38
Sicagen India Ltd is a prominent Indian conglomerate with a rich history spanning several decades. Established in 1977, the company has evolved into a diversified business group with a strong presence in various industries. Sicagen India Ltd operates primarily in the fields of trading, manufacturing, and distribution of industrial and construction products. The company's extensive product portfolio encompasses a wide range of offerings, including industrial chemicals, building materials, engineering products, and more. With a commitment to quality, innovation, and sustainability, Sicagen India Ltd has become a trusted partner for numerous businesses across India. Sicagen's dedication to customer satisfaction and its robust distribution network have contributed to its success in serving clients in sectors such as infrastructure, manufacturing, and construction. This company's enduring reputation for excellence and reliability continues to drive its growth and influence in India's industrial landscape.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 230 | 316 | 164 | 246 | 258 | 227 | 166 | 180 | 228 | 221 |
| Other Income | 2 | 3 | 2 | 3 | 2 | 1 | 1 | 1 | 3 | 1 |
| Total Income | 232 | 318 | 166 | 249 | 260 | 229 | 168 | 182 | 231 | 223 |
| Total Expenditure | 225 | 308 | 159 | 242 | 251 | 216 | 158 | 175 | 222 | 213 |
| Operating Profit | 7 | 10 | 7 | 6 | 9 | 13 | 10 | 7 | 8 | 10 |
| Interest | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 2 | 3 | 3 |
| Depreciation | 3 | 3 | 2 | 3 | 2 | 4 | 2 | 2 | 2 | 3 |
| Exceptional Income / Expenses | -0 | -0 | 0 | 0 | 0 | 6 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 2 | 6 | 3 | 1 | 4 | 13 | 5 | 2 | 3 | 4 |
| Provision for Tax | 1 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 0 |
| Profit After Tax | 1 | 4 | 2 | 1 | 3 | 11 | 4 | 1 | 2 | 3 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 1 | 4 | 2 | 1 | 3 | 11 | 4 | 1 | 2 | 3 |
| Adjusted Earnings Per Share | 0.4 | 1 | 0.6 | 0.2 | 0.9 | 2.8 | 1 | 0.3 | 0.6 | 0.8 |
| #(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 1027 | 620 | 771 | 601 | 711 | 738 | 820 | 699 | 542 | 836 | 895 | 795 |
| Other Income | 9 | 29 | 17 | 18 | 15 | 15 | 17 | 11 | 8 | 9 | 8 | 6 |
| Total Income | 1036 | 649 | 788 | 618 | 726 | 753 | 837 | 710 | 550 | 845 | 903 | 804 |
| Total Expenditure | 994 | 613 | 764 | 608 | 708 | 737 | 819 | 688 | 533 | 814 | 869 | 768 |
| Operating Profit | 42 | 36 | 23 | 11 | 18 | 16 | 18 | 22 | 17 | 31 | 35 | 35 |
| Interest | 11 | 7 | 7 | 6 | 7 | 9 | 9 | 9 | 5 | 6 | 9 | 11 |
| Depreciation | 4 | 6 | 6 | 5 | 4 | 5 | 6 | 10 | 10 | 11 | 11 | 9 |
| Exceptional Income / Expenses | -1 | -6 | -2 | 0 | 0 | 0 | 0 | 0 | 0 | -9 | 6 | 0 |
| Profit Before Tax | 26 | 17 | 8 | -1 | 8 | 2 | 3 | 3 | 1 | 5 | 22 | 14 |
| Provision for Tax | 8 | 0 | 1 | -2 | 0 | 1 | 3 | 3 | 5 | 6 | 4 | 3 |
| Profit After Tax | 18 | 17 | 7 | 1 | 7 | 1 | 0 | 0 | -3 | -1 | 18 | 10 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 18 | 17 | 7 | 1 | 7 | 1 | 0 | 0 | -3 | -1 | 18 | 10 |
| Adjusted Earnings Per Share | 4.5 | 4.3 | 1.7 | 0.3 | 1.9 | 0.3 | 0 | 0.1 | -0.8 | -0.2 | 4.5 | 2.7 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 7% | 9% | 4% | -1% |
| Operating Profit CAGR | 13% | 17% | 17% | -2% |
| PAT CAGR | 0% | 0% | 78% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 48% | 48% | 21% | 16% |
| ROE Average | 4% | 1% | 1% | 1% |
| ROCE Average | 6% | 3% | 3% | 3% |
| #(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 461 | 480 | 479 | 483 | 384 | 393 | 382 | 375 | 395 | 422 | 440 |
| Minority's Interest | 0 | 0 | 0 | 0 | 8 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 16 | 12 | 11 | 14 | 13 | 12 | 9 | 7 | 6 | 0 | 0 |
| Other Non-Current Liabilities | 36 | 41 | 35 | 36 | 21 | 21 | 21 | 33 | 15 | 15 | 17 |
| Total Current Liabilities | 162 | 140 | 86 | 89 | 176 | 201 | 300 | 209 | 152 | 243 | 195 |
| Total Liabilities | 675 | 673 | 610 | 620 | 603 | 626 | 712 | 624 | 568 | 681 | 651 |
| Fixed Assets | 60 | 64 | 59 | 57 | 183 | 203 | 148 | 165 | 165 | 138 | 137 |
| Other Non-Current Assets | 310 | 326 | 321 | 315 | 90 | 62 | 53 | 45 | 46 | 79 | 80 |
| Total Current Assets | 305 | 282 | 230 | 248 | 330 | 362 | 511 | 415 | 357 | 464 | 434 |
| Total Assets | 675 | 673 | 610 | 620 | 603 | 626 | 712 | 624 | 568 | 681 | 651 |
| #(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 36 | 43 | 28 | 22 | 31 | 17 | 13 | 16 | 5 | 8 | 6 |
| Cash Flow from Operating Activities | 16 | -14 | 2 | -3 | -41 | -12 | 20 | -37 | 31 | -2 | 15 |
| Cash Flow from Investing Activities | 8 | 17 | 2 | 9 | 5 | 11 | -5 | 45 | -17 | 18 | -4 |
| Cash Flow from Financing Activities | -17 | -18 | -11 | 4 | 22 | -4 | -12 | -18 | -12 | -18 | -13 |
| Net Cash Inflow / Outflow | 7 | -15 | -6 | 10 | -13 | -5 | 3 | -10 | 3 | -2 | -3 |
| Closing Cash & Cash Equivalent | 43 | 28 | 22 | 32 | 17 | 13 | 16 | 5 | 8 | 6 | 3 |
| # | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 4.52 | 4.27 | 1.67 | 0.27 | 1.89 | 0.29 | 0.03 | 0.09 | -0.81 | -0.15 | 4.5 |
| CEPS(Rs) | 5.59 | 5.68 | 3.3 | 1.55 | 2.89 | 1.58 | 1.61 | 2.65 | 1.7 | 2.61 | 7.17 |
| DPS(Rs) | 1 | 0.8 | 0.6 | 0.6 | 0.6 | 0.6 | 0.4 | 0.5 | 0.6 | 0.25 | 0.6 |
| Book NAV/Share(Rs) | 116.41 | 121.36 | 120.98 | 121.96 | 97.16 | 99.33 | 96.65 | 94.82 | 99.75 | 106.73 | 111.08 |
| Core EBITDA Margin(%) | 3.28 | 1.06 | 0.83 | -1.19 | 0.46 | 0.14 | 0.18 | 1.62 | 1.56 | 2.63 | 2.96 |
| EBIT Margin(%) | 3.57 | 3.79 | 1.88 | 0.9 | 1.97 | 1.44 | 1.46 | 1.75 | 1.27 | 1.3 | 3.41 |
| Pre Tax Margin(%) | 2.5 | 2.74 | 0.98 | -0.09 | 1.05 | 0.22 | 0.35 | 0.49 | 0.27 | 0.6 | 2.42 |
| PAT Margin (%) | 1.73 | 2.71 | 0.85 | 0.18 | 1.02 | 0.16 | 0.02 | 0.05 | -0.59 | -0.07 | 1.99 |
| Cash Profit Margin (%) | 2.14 | 3.6 | 1.68 | 1.02 | 1.6 | 0.84 | 0.78 | 1.5 | 1.24 | 1.23 | 3.17 |
| ROA(%) | 2.71 | 2.51 | 1.03 | 0.17 | 1.2 | 0.19 | 0.02 | 0.05 | -0.54 | -0.1 | 2.67 |
| ROE(%) | 3.96 | 3.59 | 1.38 | 0.22 | 1.69 | 0.3 | 0.03 | 0.1 | -0.83 | -0.15 | 4.14 |
| ROCE(%) | 6.72 | 4.24 | 2.7 | 1.02 | 2.78 | 2.21 | 2.42 | 2.56 | 1.51 | 2.27 | 5.82 |
| Receivable days | 40.12 | 73.41 | 55.35 | 67.97 | 67.18 | 81.75 | 100.56 | 123.66 | 126.91 | 90.97 | 88.31 |
| Inventory Days | 40.32 | 65.74 | 45.62 | 53.04 | 52.91 | 59.87 | 52.94 | 64.82 | 79.94 | 45.46 | 50.59 |
| Payable days | 16.09 | 32.44 | 21.64 | 19.62 | 24.37 | 36.72 | 56.44 | 74.2 | 59.19 | 42.55 | 40.14 |
| PER(x) | 3.1 | 3.06 | 7.47 | 62.53 | 13.66 | 124.23 | 733.57 | 94.95 | 0 | 0 | 6.73 |
| Price/Book(x) | 0.12 | 0.11 | 0.1 | 0.14 | 0.27 | 0.36 | 0.25 | 0.09 | 0.14 | 0.21 | 0.27 |
| Dividend Yield(%) | 7.15 | 6.12 | 4.8 | 3.58 | 2.33 | 1.66 | 1.66 | 5.79 | 4.17 | 1.14 | 1.98 |
| EV/Net Sales(x) | 0.11 | 0.16 | 0.1 | 0.16 | 0.24 | 0.3 | 0.17 | 0.14 | 0.16 | 0.17 | 0.22 |
| EV/Core EBITDA(x) | 2.71 | 2.72 | 3.26 | 9.03 | 9.16 | 14.2 | 7.65 | 4.32 | 5.1 | 4.57 | 5.71 |
| Net Sales Growth(%) | -2.91 | -39.67 | 24.34 | -22.07 | 18.35 | 3.81 | 11.16 | -14.81 | -22.5 | 54.37 | 7.08 |
| EBIT Growth(%) | -9.55 | -35.75 | -38.45 | -62.59 | 159.08 | -24.65 | 12.5 | 2.09 | -43.54 | 58.12 | 179.74 |
| PAT Growth(%) | -12.91 | -5.37 | -60.85 | -83.99 | 589.62 | -84.27 | -88.7 | 176.92 | -988.89 | 80.94 | 3021.31 |
| EPS Growth(%) | -12.91 | -5.37 | -60.85 | -83.99 | 603.79 | -84.59 | -88.69 | 176.99 | -988.68 | 80.93 | 3020.49 |
| Debt/Equity(x) | 0.22 | 0.15 | 0.1 | 0.13 | 0.23 | 0.25 | 0.31 | 0.21 | 0.16 | 0.19 | 0.24 |
| Current Ratio(x) | 1.88 | 2.02 | 2.69 | 2.8 | 1.87 | 1.8 | 1.71 | 1.99 | 2.34 | 1.91 | 2.22 |
| Quick Ratio(x) | 1.15 | 1.27 | 1.66 | 1.82 | 1.19 | 1.19 | 1.32 | 1.35 | 1.65 | 1.48 | 1.48 |
| Interest Cover(x) | 3.35 | 3.62 | 2.08 | 0.91 | 2.14 | 1.18 | 1.31 | 1.39 | 1.26 | 1.85 | 3.44 |
| Total Debt/Mcap(x) | 1.86 | 1.42 | 0.97 | 0.91 | 0.87 | 0.68 | 1.24 | 2.31 | 1.12 | 0.92 | 0.89 |
| # | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 38.78 | 38.78 | 38.78 | 45.67 | 45.67 | 50.57 | 50.57 | 50.57 | 55.46 | 55.46 |
| FII | 12.33 | 12.33 | 12.33 | 7.34 | 7.34 | 7.34 | 7.34 | 7.34 | 7.34 | 7.34 |
| DII | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 |
| Public | 48.28 | 48.28 | 48.28 | 46.39 | 46.39 | 41.48 | 41.48 | 41.48 | 36.59 | 36.59 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 1.53 | 1.53 | 1.53 | 1.81 | 1.81 | 2 | 2 | 2 | 2.19 | 2.19 |
| FII | 0.49 | 0.49 | 0.49 | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 | 0.29 |
| DII | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Public | 1.91 | 1.91 | 1.91 | 1.84 | 1.84 | 1.64 | 1.64 | 1.64 | 1.45 | 1.45 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3.96 | 3.96 | 3.96 | 3.96 | 3.96 | 3.96 | 3.96 | 3.96 | 3.96 | 3.96 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
You May Also Know About
